title: Low SVR rates in clinical practice for treating genotype 1 chronic hepatitis C with protease inhibitors boceprevir and telaprevir.
authors.affiliation: Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
authors.forename: Perry H
authors.initials: PH
authors.lastname: Dubin
authors.forename: Seth N
authors.initials: SN
authors.lastname: Sclair
authors.forename: Rene
authors.initials: R
authors.lastname: Rico
authors.forename: Amelia K
authors.initials: AK
authors.lastname: Boehme
authors.forename: Emerson Y
authors.initials: EY
authors.lastname: Chen
authors.forename: Paul
authors.initials: P
authors.lastname: Martin
authors.forename: William M
authors.initials: WM
authors.lastname: Lee
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000627:therapeutic use*; D011392:Proline / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D011392:Proline